Terms: = Colorectal cancer AND MUC16, CA125, CA-125
335 results:
1. Identification and validation of calcium extrusion-related genes prognostic signature in colon adenocarcinoma.
Jin M; Yin C; Yang J; Yang X; Wang J; Zhu J; Yuan J
PeerJ; 2024; 12():e17582. PubMed ID: 39006025
[TBL] [Abstract] [Full Text] [Related]
2. Predictive value of preoperative CT enhancement rate and CT perfusion parameters in colorectal cancer.
Li ZM; Zhou W; Feng L; Zhang HY; Chen WB
BMC Gastroenterol; 2024 May; 24(1):176. PubMed ID: 38773485
[TBL] [Abstract] [Full Text] [Related]
3. Exploration of the application potential of serum multi-biomarker model in colorectal cancer screening.
Xu R; Shen J; Song Y; Lu J; Liu Y; Cao Y; Wang Z; Zhang J
Sci Rep; 2024 May; 14(1):10127. PubMed ID: 38698075
[TBL] [Abstract] [Full Text] [Related]
4. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
Tan Y; Liu R; Xue JW; Feng Z
Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
[TBL] [Abstract] [Full Text] [Related]
5. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of natural killer cells injection combined with XELOX chemotherapy in postoperative patients with stage III colorectal cancer in China: a prospective randomised controlled clinical trial study protocol.
Geng S; Yu X; Yu S
BMJ Open; 2024 Mar; 14(3):e080377. PubMed ID: 38531576
[TBL] [Abstract] [Full Text] [Related]
7. Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.
Deng YY; Sun Y; Wu SJ; Zhang TY; Yang J; Liu K
J Cell Mol Med; 2024 Apr; 28(7):e18174. PubMed ID: 38494839
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer.
Ren G; Zheng G; Du K; Dang Z; Dan H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
Clin Transl Oncol; 2024 Aug; 26(8):2047-2059. PubMed ID: 38453817
[TBL] [Abstract] [Full Text] [Related]
9. Evaluating the role of wound-healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications.
Yu K; Fang X
Int Wound J; 2024 Mar; 21(3):e14768. PubMed ID: 38446012
[TBL] [Abstract] [Full Text] [Related]
10. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative CA 19-9 Predicts Disease Progression in colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
Fackche NT; Schmocker RK; Nudotor R; Kubi B; Cloyd JM; Grotz TE; Fournier KF; Dineen SP; Veerapong J; Baumgartner JM; Clarke CN; Patel SH; Wilson GC; Lambert LA; Pokrzywa C; Abbott DE; Lee B; Staley CA; Zaidi MY; Johnston FM; Greer JB
Ann Surg Oncol; 2024 May; 31(5):3314-3324. PubMed ID: 38310181
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer.
Ren G; Li R; Zheng G; Du K; Dan H; Wu H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
Sci Rep; 2023 Dec; 13(1):22830. PubMed ID: 38129505
[TBL] [Abstract] [Full Text] [Related]
13. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
[TBL] [Abstract] [Full Text] [Related]
14. Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis.
Magnusson MI; Agnarsson BA; Jonasson JG; Tryggvason T; Aeffner F; le Roux L; Magnusdottir DN; Gunnarsdottir HS; Alexíusdóttir KK; Gunnarsdottir K; Söebech E; Runarsdottir H; Jonsdottir EM; Kristinsdottir BS; Olafsson S; Knutsdottir H; Thorsteinsdottir U; Ulfarsson MO; Gudbjartsson DF; Saemundsdottir J; Magnusson OT; Norddahl GL; Watson JEV; Rafnar T; Lund SH; Stefansson K
Br J Cancer; 2023 Oct; 129(7):1142-1151. PubMed ID: 37596405
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
Cengiz A; Yersal Ö; Ömürlü İK; Yürekli Y
Indian J Cancer; 2023; 60(2):224-229. PubMed ID: 37530245
[TBL] [Abstract] [Full Text] [Related]
16. Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis.
He Y; He X; Zhou Y; Luo S
BMC Cancer; 2023 Jul; 23(1):707. PubMed ID: 37507669
[TBL] [Abstract] [Full Text] [Related]
17. Early Screening of colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis.
Ke X; Liu W; Shen L; Zhang Y; Liu W; Wang C; Wang X
Biosensors (Basel); 2023 Jun; 13(7):. PubMed ID: 37504084
[TBL] [Abstract] [Full Text] [Related]
18. Electrochemical biotool for the dual determination of epithelial mucins associated to prognosis and minimal residual disease in colorectal cancer.
Tejerina-Miranda S; Blázquez-García M; Serafín V; Montero-Calle A; Garranzo-Asensio M; Reviejo AJ; Pedrero M; Pingarrón JM; Barderas R; Campuzano S
Int J Biol Macromol; 2023 Sep; 248():125996. PubMed ID: 37499706
[TBL] [Abstract] [Full Text] [Related]
19. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract] [Full Text] [Related]
20. Minimally invasive surgery versus laparotomy of nonmetastatic pT4a colorectal cancer: a propensity score analysis.
Guo HL; Chen JY; Tang YZ; Zeng QL; Jian QL; Li MZ; He YL; Wu WH
Int J Surg; 2023 Nov; 109(11):3294-3302. PubMed ID: 37462996
[TBL] [Abstract] [Full Text] [Related]
[Next]
